Similar to NPM::ALK Hdac1KO mice, NPM::ALK dHdac1KI mice exhibited highly accelerated lymphomagenesis and developed thymic tumors with a median survival of 9.4 weeks (Fig. 3B). Here, ALK is linked to thymus neoplasm.